| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |